Can an online tool help young breast cancer patients make better fertility choices?
NCT ID NCT03591848
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether an online decision support tool helps young women (18-40) with breast cancer make more informed choices about preserving their fertility before starting cancer treatment. 186 participants either received standard oral information alone or used the online tool beforehand. Researchers measured decision-making quality and anxiety levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Online decision support tool
- What this could lead to
- If successful, this tool could help young breast cancer patients feel more confident and informed when deciding about fertility preservation.
- What could go wrong
- This is a completed behavioral study, not a treatment trial. The tool may not improve decision-making for all patients, and results may not apply outside French-speaking populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
186 people
The number who actually took part.
- Started
-
Sep 2018
- Finished
-
Mar 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18-40 years women * with breast cancer * cancer treatment not started, no antecedent of chemotherapy * speaking French * affiliated in Social Insurance Exclusion Criteria: * recurrence of breast cancer * metastatic breast cancer * pregnancy in progress * Adults protected (wardship, guardianship, protection of justice)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Reproduction medicine and fertility preservation ANTOINE BECLERE Hospital
Clamart, 92140, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?